Overview

Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the incidence rate of gout flare for subjects with gout and hyperuricemia treated by two different starting doses of febuxostat.
Phase:
N/A
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborator:
National Taiwan University Hospital, Yun-Lin Branch
Treatments:
Colchicine
Febuxostat